248 related articles for article (PubMed ID: 31127885)
21. Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-κB signaling pathway in vitro and in vivo.
Tian F; Fan T; Zhang Y; Jiang Y; Zhang X
Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):847-55. PubMed ID: 23017833
[TBL] [Abstract][Full Text] [Related]
22. Potential Mechanisms of Action of Curcumin for Cancer Prevention: Focus on Cellular Signaling Pathways and miRNAs.
Wang M; Jiang S; Zhou L; Yu F; Ding H; Li P; Zhou M; Wang K
Int J Biol Sci; 2019; 15(6):1200-1214. PubMed ID: 31223280
[TBL] [Abstract][Full Text] [Related]
23. Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS).
van Heijl M; van Lanschot JJ; Koppert LB; van Berge Henegouwen MI; Muller K; Steyerberg EW; van Dekken H; Wijnhoven BP; Tilanus HW; Richel DJ; Busch OR; Bartelsman JF; Koning CC; Offerhaus GJ; van der Gaast A
BMC Surg; 2008 Nov; 8():21. PubMed ID: 19036143
[TBL] [Abstract][Full Text] [Related]
24. Phase II trial of neoadjuvant chemotherapy with docetaxel, nedaplatin, and S1 for advanced esophageal squamous cell carcinoma.
Tanaka Y; Yoshida K; Tanahashi T; Okumura N; Matsuhashi N; Yamaguchi K
Cancer Sci; 2016 Jun; 107(6):764-72. PubMed ID: 27061001
[TBL] [Abstract][Full Text] [Related]
25. Neoadjuvant therapy for squamous cell esophageal carcinoma.
Fink U; Stein HJ; Bochtler H; Roder JD; Wilke HJ; Siewert JR
Ann Oncol; 1994; 5 Suppl 3():17-26. PubMed ID: 8204527
[TBL] [Abstract][Full Text] [Related]
26. In vivo and in vitro effects of curcumin on head and neck carcinoma: a systematic review.
Borges GÁ; Rêgo DF; Assad DX; Coletta RD; De Luca Canto G; Guerra EN
J Oral Pathol Med; 2017 Jan; 46(1):3-20. PubMed ID: 27219631
[TBL] [Abstract][Full Text] [Related]
27. Randomized study of low-dose versus standard-dose chemoradiotherapy for unresectable esophageal squamous cell carcinoma (JCOG0303).
Shinoda M; Ando N; Kato K; Ishikura S; Kato H; Tsubosa Y; Minashi K; Okabe H; Kimura Y; Kawano T; Kosugi S; Toh Y; Nakamura K; Fukuda H;
Cancer Sci; 2015 Apr; 106(4):407-12. PubMed ID: 25640628
[TBL] [Abstract][Full Text] [Related]
28. [No improvement of prognosis by neoadjuvant chemotherapy alone in operable esophageal carcinoma].
Fietkau R
Strahlenther Onkol; 1999 May; 175(5):251-2. PubMed ID: 10356618
[No Abstract] [Full Text] [Related]
29. Neoadjuvant chemoradiotherapy for clinical stage II-III esophageal squamous cell carcinoma.
Saeki H; Morita M; Nakashima Y; Sonoda H; Hashimoto K; Egashira A; Oki E; Ohga T; Kakeji Y; Maehara Y
Anticancer Res; 2011 Sep; 31(9):3073-7. PubMed ID: 21868562
[TBL] [Abstract][Full Text] [Related]
30. Esophageal cancer: The latest on chemoprevention and state of the art therapies.
Le Bras GF; Farooq MH; Falk GW; Andl CD
Pharmacol Res; 2016 Nov; 113(Pt A):236-244. PubMed ID: 27565381
[TBL] [Abstract][Full Text] [Related]
31. Preoperative therapy with concurrent paclitaxel/carboplatin/infusional 5-FU and radiation therapy in locoregional esophageal cancer: final results of a Minnie Pearl Cancer Research Network phase II trial.
Meluch AA; Greco FA; Gray JR; Thomas M; Sutton VM; Davis JL; Kalman LA; Shaffer DW; Yost K; Rinaldi DA; Hainsworth JD
Cancer J; 2003; 9(4):251-60. PubMed ID: 12967135
[TBL] [Abstract][Full Text] [Related]
32. Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy.
Miyata H; Yoshioka A; Yamasaki M; Nushijima Y; Takiguchi S; Fujiwara Y; Nishida T; Mano M; Mori M; Doki Y
Cancer; 2009 Jul; 115(14):3324-34. PubMed ID: 19452547
[TBL] [Abstract][Full Text] [Related]
33. Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network phase II trial.
Meluch AA; Hainsworth JD; Gray JR; Thomas M; Whitworth PL; Davis JL; Greco FA
Cancer J Sci Am; 1999; 5(2):84-91. PubMed ID: 10198730
[TBL] [Abstract][Full Text] [Related]
34. Is Curcumin the Answer to Future Chemotherapy Cocktail?
Kong WY; Ngai SC; Goh BH; Lee LH; Htar TT; Chuah LH
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299604
[TBL] [Abstract][Full Text] [Related]
35. [Esophageal carcinoma: non-surgical therapy].
Geissler M; Schwacha H; Eggstein S; Usadel H; Harder J; Opitz O; Arnold C; Grimm CF; Blum HE
Praxis (Bern 1994); 2004 Dec; 93(49):2057-64. PubMed ID: 15630988
[TBL] [Abstract][Full Text] [Related]
36. The anticancer effects of curcumin and clinical research progress on its effects on esophageal cancer.
Wang S; Gao X; Li J; Wei S; Shao Y; Yin Y; Zhang D; Tang M
Front Pharmacol; 2022; 13():1058070. PubMed ID: 36386215
[TBL] [Abstract][Full Text] [Related]
37. [Chemotherapy of esophageal and cardial carcinomas].
Nagel GA; Scherpe A
Langenbecks Arch Chir; 1981; 355():77-80. PubMed ID: 7339390
[TBL] [Abstract][Full Text] [Related]
38. [Multimodality management of squamous cell carcinoma of thoracic esophagus].
Wang ZX; Mao T; Guo XF; Fang WT
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Sep; 16(9):815-8. PubMed ID: 24061983
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the effect of p65 siRNA and curcumin in promoting apoptosis in esophageal squamous cell carcinoma cells and in nude mice.
Tian F; Zhang C; Tian W; Jiang Y; Zhang X
Oncol Rep; 2012 Jul; 28(1):232-40. PubMed ID: 22552693
[TBL] [Abstract][Full Text] [Related]
40. The Cancer Chemopreventive and Therapeutic Potential of Tetrahydrocurcumin.
Lai CS; Ho CT; Pan MH
Biomolecules; 2020 May; 10(6):. PubMed ID: 32486019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
